SLU-PP-332 for endurance capacity: what the data actually shows

Ever wonder if there's a pill that trains your muscles for you while you sit on the couch? Yeah, I know how that sounds. Short answer: SLU-PP-332 for endurance capacity has real, honest-to-God mouse data behind it, mice ran farther and longer on it, but there is not one single human trial, so treat it as a compound to watch, not a protocol to run today.

I'm a proud geek about receptor biology, and this one genuinely gets me excited. Not because it's a magic pill (there is no magic pill, EVER), but because the mechanism here is weirder and more specific than the usual "burns fat" story you hear about every new research chemical.

What SLU-PP-332 actually is, and why "endurance" is the right word for it

SLU-PP-332 isn't a peptide at all. It's a small molecule. But it lives in the same "exercise in a vial" conversation as the SLU-PP-322 encyclopedia entry covers in more depth. It's a pan-ERR agonist. ERR stands for estrogen-related receptor, and yes, I know that name is a trap, it has NOTHING to do with estrogen levels in men or women. Think of ERRs as the light switches for your mitochondria, the tiny power plants inside every muscle cell. Flip them on and the cell starts behaving like it just got back from a hard bike ride: more mitochondria, more fat-burning enzymes, more energy output. SLU-PP-332 flips all three ERR switches, with its strongest grip on the one called ERR-alpha, which researchers have identified as the main driver of the whole endurance response.

What the mouse data actually shows

Here's the part that matters if you're asking about endurance specifically, not just weight. Researchers at a University of Florida pharmacology lab ran mice on this compound and watched what happened inside the muscle itself. The muscle physically remodeled. More of a fatigue-resistant fiber type showed up. PGC-1alpha, the master switch for building new mitochondria, the same one exercise flips, went up. GLUT4, the transporter that pulls sugar into muscle for fuel, went up too. And when they actually ran the mice, treated animals went farther and longer than untreated ones. When the researchers blocked ERR-alpha specifically, the endurance boost disappeared. That's the mechanism, confirmed.

That's a genuinely different story from your typical fat-loss compound. Caffeine, ephedrine, the whole thermogenic aisle, they all work by cranking up your sympathetic nervous system: your heart races, you get jittery, you sleep like garbage. SLU-PP-332 doesn't touch that system at all in the animal data. No heart rate change. No jitters. It's working at the level of gene expression, telling the cell to act like it already trained, instead of stimulating it to panic.

There's a related compound worth mentioning here too. A 2026 study on SLU-PP-915, a close cousin in the same ERR-agonist family, showed enhanced aerobic exercise capacity in mice through the exact same receptor logic. Not the same molecule. Same neighborhood. And it's more evidence the ERR pathway itself is a legitimate lever, not a one-off fluke from a single lab.

This isn't only an endurance story either. A separate paper found that ERR agonism reversed kidney dysfunction in aging mice, less albuminuria, less inflammation, over an eight-week course. That's a different organ system entirely responding to the same switch. When one mechanism shows up doing good things in two unrelated tissues, that's a point in favor of it being real biology, not noise.

Here's where I have to be honest with you: it's ALL mice

Zero human trials. Not one. None of the endurance numbers, none of the fiber-type data, none of it has been run in a person yet, and I'm not going to dress that up for you. Damn, I wish I had better news on that front, because the mechanism is genuinely one of the more interesting ones I've read this year.

Here's the flip side though, and it matters: the fact that nobody's funded a human trial yet doesn't mean the biology doesn't hold. It means the biology hasn't been TESTED in us yet. BIG difference. But you need to know which one you're looking at before you get excited.

And frankly, the anti-doping world is already paying attention. A 2026 paper specifically characterized SLU-PP-332's metabolites for detection purposes, the exact same playbook that got built around AICAR years back. When the doping-control labs start building a detection assay for your compound before it's even been through a human trial, that tells you something about how seriously the performance world already takes it.

This is where I bring up the house foundations thing, because it applies HARD here. You cannot decorate a house that has no foundation. If your actual training, your actual mileage, your actual sleep and protein and consistency aren't in place, NO pan-ERR agonist on this earth is going to build your endurance for you on its own. This compound, if it ever pans out in humans, is an amplifier of adaptation. It is not a replacement for doing the work. Skip the crawl-walk-run part and you're just an expensive experiment. If you want the full honest case on where the line sits for unproven, preclinical-only compounds generally, I laid it out separately in are peptides dangerous.

Dosing, reconstitution, and the boring stuff I still have to say

There's no established human dose because there's no human data, period, so I'm not going to hand you a made-up number and pretend otherwise. What I can tell you: SLU-PP-332 doesn't dissolve in water. It's a hydrophobic molecule that needs DMSO to go into proper solution, which is not a "grab your bac water and go" situation like your typical peptide vial. That alone tells you where this compound sits on the maturity curve. DMSO handling isn't beginner stuff, and the folks using it right now are the research-grade early adopters, not the average GLOW-and-BPC crowd.

Now the part my lawyer makes me say, and honestly he's right: The doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

Nobody's turned this into a human endurance protocol yet. When that changes, I'll be first in line to read the paper. Until then, this one's a watch, not a buy-and-run.

Thanks for reading! In health, Rick Gold